Sleep Disorders Trial, Recruiting (NCT06896448)

Sleep Disorders Trial, Recruiting NCT06896448 Sponsor: University Hospital, Caen Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT06896448 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults who are being investigated for a suspected cancer in the head or neck area, where the cancer is then confirmed — this includes cancers in the nasopharynx, nasal cavities, sinuses, mouth, throat, voice box, or parotid gland (a saliva gland near the ear).
People who are willing and able to sign a consent form agreeing to take part in the study.
People who are enrolled in the French social security system.

Who may not be able to join:

People who are under 18, or those who are under a form of legal protection such as guardianship or court-appointed supervision.
People whose suspected lesion turns out not to be cancerous.
People who have been diagnosed with cancer that has spread to other parts of the body (metastatic cancer).
People who have a known history of obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) or who have previously been treated for a head or neck cancer.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33231065461

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06896448

Sponsor: University Hospital, Caen

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: +33231065461

More information: https://clinicaltrials.gov/study/NCT06896448

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults who are being investigated for a suspected cancer in the head or neck area, where the cancer is then confirmed — this includes cancers in the nasopharynx, nasal cavities, sinuses, mouth, throat, voice box, or parotid gland (a saliva gland near the ear).
People who are willing and able to sign a consent form agreeing to take part in the study.
People who are enrolled in the French social security system.

Who may not be able to join:

People who are under 18, or those who are under a form of legal protection such as guardianship or court-appointed supervision.
People whose suspected lesion turns out not to be cancerous.
People who have been diagnosed with cancer that has spread to other parts of the body (metastatic cancer).
People who have a known history of obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) or who have previously been treated for a head or neck cancer.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Caen

Registry

ClinicalTrials.gov

Start date

16 September 2025

Est. completion

16 September 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Measurement of the rate of usable collected data at 6 months after treatment, with an interim analysis after the first consultation and initial recording, meaning a given Apnea-Hypopnea Index (AHI) from at least 6 hours of overnight recording

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov